Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 99-11-6 | MDL No. : | MFCD00006274 |
Formula : | C6H5NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CSGQJHQYWJLPKY-UHFFFAOYSA-N |
M.W : | 155.11 | Pubchem ID : | 7425 |
Synonyms : |
|
Chemical Name : | 6-Hydroxy-2-oxo-1,2-dihydropyridine-4-carboxylic acid |
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 36.05 |
TPSA : | 90.39 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.74 cm/s |
Log Po/w (iLOGP) : | 0.34 |
Log Po/w (XLOGP3) : | -0.69 |
Log Po/w (WLOGP) : | -0.22 |
Log Po/w (MLOGP) : | -0.31 |
Log Po/w (SILICOS-IT) : | 0.43 |
Consensus Log Po/w : | -0.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -0.7 |
Solubility : | 30.6 mg/ml ; 0.197 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.73 |
Solubility : | 28.7 mg/ml ; 0.185 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.72 |
Solubility : | 29.8 mg/ml ; 0.192 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.73 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85.18% | With urea In water at 185℃; for 2 h; Sonication; High pressure | (1) Take 1.2188 g (0.0058 mol) of citric acid and 1.3932 g (0.0231 mol) of urea dissolved in 60 ml of deionized water, sonicate for 10 min, and mix well; (2) The mixture is charged into the reaction vessel, the oven temperature is set to 185 ° C, and the temperature is kept under hydrothermal conditions for 2 h; Cooling to room temperature to obtain a dark green solution; (3) The solution was placed in a constant temperature water bath at 60 ° C, magnetically stirred, and 98percent sulfuric acid was added dropwise to the solution until the pH of the solution was 2-3. A large amount of yellow solid precipitate was observed and centrifuged at 12000 r/min for 10 min. Remove the supernatant, wash it with deionized water multiple times, and drain it. The obtained yellow precipitate was dried in an oven at 60 ° C to obtain 85.18percent of the citrazinic acid product. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | at 130 - 145℃; for 20 h; | Citrazinic acid (10.35 g, 66.7 mmol) and tetraethylammonium chloride (11.05 g, 66.7 mmol) were suspended in phosphoroxychloride (20 mL, excess) and heated at 130 °C for 18 h and then at 145 °C for 2 h. The reaction mixture was allowed to cool to RT and poured onto crushed ice (150 g). Extraction of ethyl acetate (3 x 100 mL), drying of the combined organic layers (MGS04) and evaporation in vacuo gave 11. 34 g (89 percent) of a white solid. IH NMR (400 MHz, DMSO-d6) 8 7.85 (s, 2H) 13.90 (br s, OH). |
81% | Stage #1: at 140℃; for 24 h; Stage #2: at 0℃; for 2 h; |
Citrazinic acid 1 (20.0 g, 129 mmol) and benzyltriethylammonium chloride (32.3 g, 142 mmol) in 40 ml of POCl3 were heated to 140 °C for 24 h under a CaCl2 drying tube. After being cooled to room temperature, the brown mixture was poured on ice (400 g) and stirred for 2 h. The resulting brown solid was filtered off, washed with water and dissolved in EtOAc (400 ml). The organic phase was then washed with saturated NH4Cl, dried over Na2SO4 and evaporated to dryness to afford 20 g (81percent) of the desired compound as a brown solid. 1H and 13C NMR were in accordance with those already reported.18 |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | Stage #1: at 180℃; for 3 h; Stage #2: at 0℃; |
Example 15; Synthesis of 2, 6-Dibromoisonicotinic Acid; [0114] Citrazinic acid (2.33 g, 0.015 moles) and phosphorous oxybromide were combined and heated to 180 °C under a nitrogen atmosphere for three hours. The cooled reaction was carefully quenched with ice-water. The mixture was filtered and the aqueous portion extracted with dichloromethane (4 x 40 ml). The solids were extracted in a Soxhlet extractor with dichloromethane for twelve hours. The organic portion from the direct extraction was dried over sodium sulfate, filtered, and stripped to give 2.2 g of reddish solid. The organic portion from the Soxhlet extraction was dried over sodium sulfate, filtered, and stripped to give 0.5 g of reddish solid. The two portions of 2,6- dibromoisonicotinic acid (64 percent yield) were similar by NMR and were combined.'H NMR (CDC13) 8. 04 (2H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | Stage #1: at 130℃; Stage #2: at 0℃; |
A mixture of citrazinic acid (5.0 g, 32.2 mmol) and POBr3 (27.5 g, 96.8 mmol) is heated at 130 0C. Upon completion of the reaction, the thick slurry is cooled to 0 0C and the reaction is carefully quenched with MeOH (250 ml_). The reaction mixture is concentrated in vacuo and then extracted between dichloromethane and sat. aq. NaHCO3. Organic layer is dried over anhydrous Na2SO4 and concentrated in vacuo to give a tan solid that is clean enough by NMR/LCMS to use further (7.5 g, 79percent). (ESI) m/z 295.8 (M+1 ). 1H NMR (400 MHz, CD2CI2) δ ppm 8.10 (s, 2 H), 4.05 (s, 3 H). |
50% | Stage #1: at 185℃; for 8 h; Inert atmosphere Stage #2: at 20℃; Reflux |
The compound PBr3 (21.8 ml, 0.232 mol) was loaded into a 250 ml three -neck flask cooled in a room temperature water bath under a flow of nitrogen. Br 2 (11.9 ml, 0.231 mol) was then added dropwise with stirring to PBr 3 to yield a yellow solid (PBr5). 30 minutes was taken for addition of Br 2. P2O5 (12.0 g, 0.083 mol) was then <n="64"/>added and the solid mixture was mixed well with a spatula under a flow of nitrogen. A reflux condenser was added via a connection to a water -filled bubbler, to trap evolved HBr. The mixture was heated to 98 0C for 2 hours and then cooled to room temperature. Citrazinic acid (20.0 g, 0.128 mol) was then added and the solid was mixed thoroughly with a spatula under a flow of nitrogen. The mixture was heated at 1850C for 8 hours. The mixture was cooled back to room temperature. Methanol (150 ml) was slowly added (the reaction with methanol was exothermic, causing the solution to reflux). After the addition of methanol, the mixture was stirred until room temperature. Solid NaHCO3 was added slowly until bubbling stopped. After which, water (300 ml) was added and then additional NaHCO 3 was added until the bubbling stopped. A brown solid product was collected with filtration. The solid was washed with water and dried at room temperature under air. The product was purified by silica gel column using hexanes/ethyl acetate (9: 1) as a solvent. The final pure white product was obtained by recrystallization from methanol/water: 19.02 g (50.0percent).1H NMR (CDCl 3): δ 8.00 (s, 2H), 3.97 (s, 3H). 13C NMR (CDCl3): δ 162.74, 141.35, 141.25, 126.56, 53.38. MS (EI) m/z (percent): 294.8 (100percent) [M +]. |
[ N/A ]
2-Oxo-1,2-dihydropyridine-4-carboxylic acid
Similarity: 0.83
[ 1123169-39-0 ]
1-Ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid
Similarity: 0.80
[ 33972-97-3 ]
1-Methyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid
Similarity: 0.79
[ 5006-66-6 ]
6-Oxo-1,6-dihydropyridine-3-carboxylic acid
Similarity: 0.73
[ N/A ]
2-Oxo-1,2-dihydropyridine-4-carboxylic acid
Similarity: 0.83
[ 1123169-39-0 ]
1-Ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid
Similarity: 0.80
[ 89937-77-9 ]
Methyl 1,2-dihydro-2-oxopyridine-4-carboxylate
Similarity: 0.80
[ 33972-97-3 ]
1-Methyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid
Similarity: 0.79
[ 5006-66-6 ]
6-Oxo-1,6-dihydropyridine-3-carboxylic acid
Similarity: 0.73